November 21, 2016 - By Nellie Frank · 0 Comments
The stock of Walgreen Boots Alliance Incorporated (NASDAQ:WBA) registered a decrease of 2.3% in short interest. WBA’s total short interest was 10.11M shares in November as published by FINRA. Its down 2.3% from 10.35M shares, reported previously. With 4.93M shares average volume, it will take short sellers 2 days to cover their WBA’s short positions. The short interest to Walgreen Boots Alliance Incorporated’s float is 1.08%. About 186,706 shares traded hands. Walgreens Boots Alliance Inc (NASDAQ:WBA) has risen 1.75% since April 19, 2016 and is uptrending. It has underperformed by 2.11% the S&P500.
Walgreens Boots Alliance, Inc. is a holding company. The company has a market cap of $91.12 billion. The Firm is a pharmacy-led health and wellbeing company. It has a 21.97 P/E ratio. The Firm operates through three divisions: Retail Pharmacy USA, Retail Pharmacy International and Pharmaceutical Wholesale.
Out of 11 analysts covering Walgreens Boots Alliance (NASDAQ:WBA), 9 rate it a “Buy”, 1 “Sell”, while 1 “Hold”. This means 82% are positive. Walgreens Boots Alliance has been the topic of 20 analyst reports since August 24, 2015 according to StockzIntelligence Inc. Credit Suisse maintained Walgreens Boots Alliance Inc (NASDAQ:WBA) rating on Thursday, September 1. Credit Suisse has “Outperform” rating and $95 price target. The firm has “Buy” rating by Jefferies given on Monday, October 17. The rating was initiated by Wells Fargo with “Outperform” on Monday, October 31. The firm has “Underperform” rating by Wood given on Friday, July 22. The stock of Walgreens Boots Alliance Inc (NASDAQ:WBA) earned “Buy” rating by UBS on Thursday, October 6. Cowen & Co upgraded the stock to “Outperform” rating in Wednesday, September 9 report. Zacks downgraded Walgreens Boots Alliance Inc (NASDAQ:WBA) on Monday, August 24 to “Buy” rating. Zacks upgraded the shares of WBA in a report on Tuesday, September 1 to “Hold” rating. Bank of America maintained the stock with “Buy” rating in Tuesday, June 7 report. The rating was maintained by S&P Research on Thursday, October 29 with “Buy”.
Walgreens Boots Alliance, Inc., incorporated on September 2, 2014, is a holding company. The Firm is a pharmacy-led health and wellbeing company. The Firm operates through three divisions: Retail Pharmacy USA, Retail Pharmacy International and Pharmaceutical Wholesale. The Retail Pharmacy USA segment consists of the Walgreen Co. (Walgreens) business, which includes the operation of retail drugstores, care clinics and providing specialty pharmacy services. The Retail Pharmacy International segment consists primarily of the Alliance Boots pharmacy-led health and beauty stores, optical practices and related contract manufacturing operations. The Pharmaceutical Wholesale segment consists of the Alliance Boots pharmaceutical wholesaling and distribution businesses. The Company’s portfolio of retail and business brands includes Walgreens, Duane Reade, Boots and Alliance Healthcare, as well as global health and beauty product brands, including No7, Botanics, Liz Earle and Soap & Glory.
More important recent Walgreens Boots Alliance Inc (NASDAQ:WBA) news were published by: Investorplace.com which released: “Walgreens Boots Alliance Inc (WBA) Sues Theranos for $140 Million” on November 09, 2016, also Nasdaq.com published article titled: “Walgreens Boots Alliance, Inc. (WBA) Ex-Dividend Date Scheduled for November …”, Forbes.com published: “Ex-Dividend Reminder: Wynn Resorts, Walgreens Boots Alliance and Starbucks” on November 11, 2016. More interesting news about Walgreens Boots Alliance Inc (NASDAQ:WBA) was released by: Seekingalpha.com and their article: “Why I Prefer Walgreens To CVS Health” with publication date: November 16, 2016.
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.
By Nellie Frank